Abstract:Background: The association between coffee consumption and incident hypertension remained inconsistent. Objective: This study aimed to examine the association of consumption of coffee, including different types (instant and ground) and with different additives, with new-onset hypertension, and evaluate whether genetic variation in caffeine metabolism and inflammation may modify the association. Design: This study utilized a prospective cohort design. Participants/setting: A total of 98 765 participants free of hypertension enrolled in the UK Biobank between 2006 and 2010 were included. Dietary coffee consumption was collected using 24-hour dietary recall questionnaires. Main outcome measures: The study outcome was new-onset hypertension, ascertained by self-reported medical conditions, hospital inpatient records, death registers, and primary care records. Statistical analyses performed: Cox proportional hazards models were used to estimate hazard ratio and 95% CI. Potential modifying effects were assessed by likelihood ratio testing. Results: During a median follow-up of 12.1 years, 7090 (7.2%) new-onset cases of hypertension were documented. Overall, regardless of coffee type (instant or ground) and whether adding milk to coffee, there was a U-shaped association between unsweetened coffee consumption and new-onset hypertension, with a 14% to 18% reduction of hypertension risk at >1 to ≤4 drinks per day, whereas a null association was observed between sweetened coffee consumption and the risk of new-onset hypertension. Relative to coffee nonconsumers, the adjusted hazard ratio (95% CI) of new-onset hypertension for participants who drinking unsweetened coffee 1 or fewer, >1 to 2, >2 to 3, >3 to 4, and >4 drinks/day were 0.92 (95% CI 0.85 to 1.00), 0.82 (95% CI 0.76 to 0.89), 0.86 (95% CI 0.79 to 0.96), 0.86 (95% CI 0.77 to 0.96), and 0.88 (95% CI 0.78 to 0.99), respectively. Moreover, a stronger inverse association between moderate consumption of unsweetened coffee and new-onset hypertension was found in participants with higher C-reactive protein levels (P for interaction =.012), whereas an individual's genetic variation in caffeine metabolism did not significantly modify the association (P for interaction = .453). Conclusions: Regardless of the type of coffee (instant or ground) or the addition of milk to coffee, moderate consumption of unsweetened coffee (>1 to ≤4 drinks/day), but not sweetened coffee, was associated with a lower risk of new-onset hypertension.

Immediate effect of caffeine on sympathetic nerve activity: why coffee is safe? A single-centre crossover study

Coffee and blood pressure: exciting news!

Acute Effects of Coffee Consumption on Blood Pressure and Endothelial Function in Individuals with Hypertension on Antihypertensive Drug Treatment: A Randomized Crossover Trial

The effect of caffeine on cutaneous postocclusive reactive hyperaemia

Diagnostic Ultrasound-Based Investigation of Central vs. Peripheral Arterial Changes Consequent to Low-Dose Caffeine Ingestion

CENTRAL AND PERIPHERAL HAEMODYNAMIC RESPONSE TO COFFEE CONSUMPTION IN THE COHORT OF THE BRISIGHELLA HEART STUDY

The impact of coffee consumption on blood pressure, cardiovascular disease and diabetes mellitus

PS 14-82 COFFEE CONSUMPTION IS A PREDICTOR OF PREDIABETES AND CARDIOVASCULAR EVENTS IN YOUNG STAGE I HYPERTENSIVES

Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study

Cardiovascular symptoms affect the patterns of habitual coffee consumption

Long-term outcomes from the UK Biobank on the impact of coffee on cardiovascular disease, arrhythmias, and mortality: Does the future hold coffee prescriptions?

Long-Term Coffee Consumption Is Associated with Decreased Incidence of New-Onset Hypertension: A Dose–Response Meta-Analysis

A Moderate Dosage of Coffee Causes Acute Retinal Capillary Perfusion Decrease in Healthy Young Individuals

The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank

Acute effect of coffee on arterial stiffness and endothelial function in overweight and obese individuals: A randomized clinical trial

Optical Coherence Tomography Angiography: Investigating Vessel Density Changes Induced by Caffeine in Healthy Subjects

Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study

COFFEE CONSUMPTION RELATES TO A REDUCTION OF VASCULAR AND HEART DAMAGE IN WELL-CONTROLLED HYPERTENSIVES

The acute effects of coffee ingestion on postural control and physical function in older adults: A randomised crossover trial

A meta-analysis and systematic review of randomized clinical trials on the effect of coffee consumption on heart rate

Evaluation of the Association Between Coffee Consumption, Including Type (Instant, Ground), and Addition of Milk or Sweeteners and New-Onset Hypertension and Potential Modifiers